AmCad BioMed
About AmCad BioMed
AmCad BioMed is a pioneering healthcare AI company specializing in advanced ultrasound solutions designed to enhance diagnostic accuracy and streamline clinical workflows. Their patented AI technologies assist physicians in the early and precise detection of various conditions by providing detailed quantification and visualization of sonographic characteristics. The company’s product portfolio includes AmCAD-UT for thyroid nodule analysis, AmCAD-UO for obstructive sleep apnea (OSA) assessment, AmCAD-UB for breast ultrasound with BI-RADS insights, and AmCAD-US for general soft tissue analysis. These FDA and CE certified devices, such as the AmCAD-UT® Detection software, analyze ultrasound images for key features like echogenic foci, echogenicity, texture, margin, and nodule size, offering objective data to support diagnostic decisions and potentially reduce indeterminate cases.
Furthermore, AmCad BioMed is advancing real-time AI integration, exemplified by their AmCAD-UT® LIVE handheld ultrasound system. This system enables physicians to immediately assess the malignancy of thyroid nodules during examinations, eliminating the need for separate image exports and significantly improving diagnostic efficiency and accuracy, which can lead to a reduction in unnecessary surgical interventions. The company is committed to addressing unmet medical needs through continuous R&D and clinical validation, expanding its focus to areas like fatty liver, liver fibrosis, and ultrasound-guided interventions for musculoskeletal therapy.
Focus Areas
Business Intelligence
| Key Investors | Fann Sun Precision Co., Ltd. (strategic partner), PhytoHealth Corp. (parent company), Maywufa Healthcare Group |
| Partnerships | Geneva University Hospital (Switzerland), UAE (MOU), National Taiwan University Hospital's Health Management Center, China Medical University Hospital, Good Liver Clinic, Harvard Health Clinic, Sunshine Clinic, Stanford Sleep Center, Bern University Hospital |
| Technology | AI-powered ultrasound imaging, Computer-Assisted Detection (CAD), patented algorithms, deep-learning, integration with Point-of-Care Ultrasound (POCUS) manufacturers |
| FDA Clearances | 4+ cleared products (estimated) |
What Physicians Need to Know
AmCad BioMed's AI-powered ultrasound solutions are designed to seamlessly integrate into existing clinical workflows, offering physicians enhanced diagnostic accuracy and efficiency. Their systems provide objective, quantitative data and visualized sonographic features, which can significantly bolster clinical expertise and reduce inter-observer variability. The automated report generation feature streamlines documentation, freeing up valuable time. With a strong emphasis on early detection across various specialties, these tools facilitate timely interventions and contribute to improved patient outcomes. Furthermore, the compatibility with a wide range of ultrasound systems, including handheld devices, offers flexibility for diverse clinical settings and point-of-care diagnostics.
AmCad BioMed's software solutions are engineered for robust integration into standard medical imaging environments, including PACS. They demonstrate broad compatibility with various commercial ultrasound systems, ensuring flexibility for healthcare providers. The company is actively pursuing integration of its AI ultrasound technology with major international Point-of-Care Ultrasound (POCUS) manufacturers to develop handheld devices with real-time AI diagnostic capabilities. Deployment options include both cloud-based and local installations on dedicated hardware, and the systems support output in standard formats such as DICOM and PDF for efficient archiving and sharing.
What the Web Says
AmCad BioMed appears to be a company with mixed reviews, particularly concerning its employer practices. While some employees found the workplace productive and the staff friendly, others reported issues with work-life balance, low pay, and job security. The company also offers a product called AmCAD-UT, an AI-assisted software for analyzing thyroid ultrasound images, which has received FDA clearance.
Overall: MixedStrengths
- Productive workplace with friendly staff (reported by some employees).
- Opportunities for advancement (reported by some employees).
- AmCAD-UT software aids in clinical decision-making for thyroid nodule biopsy recommendations.
- AmCAD-UT quantifies and visualizes sonographic features of thyroid nodules.
- AmCAD-UT generates automated reports for thyroid cancer diagnosis and management.
- AmCAD-UT uses AI contouring algorithms for defining regions of interest on ultrasound images.
Limitations
- Poor work-life balance.
- Low pay and benefits.
- Lack of job security and advancement opportunities (reported by some employees).
- Unstable work environment.
- Allegations of forcing H1 developers to work weekends without compensation.
- Over-hiring and then letting go of temporary employees.
Based on reviews from: Indeed.com, X-ray Interpreter (FDA Radiology AI Device), G2, Capterra
Last updated: 2026-07-17
Videos
News, demos, and interviews about AmCad BioMed.
Videos load interactively. If none appear, search YouTube for AmCad BioMed →
Frequently Asked Questions
Related Companies
Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]
Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]
Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]
Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]
Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]
SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]